Stevanato Group S.p.A. (STVN) News
Filter STVN News Items
STVN News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
STVN News Highlights
- For STVN, its 30 day story count is now at 5.
- Over the past 23 days, the trend for STVN's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- DRUG and PEN are the most mentioned tickers in articles about STVN.
Latest STVN News From Around the Web
Below are the latest news stories about Stevanato Group SpA that investors may wish to consider to help them evaluate STVN as an investment opportunity.
Stevanato Group to Report Fourth Quarter Financial Results on March 8, 2022PIOMBINO DESE, Italy--(BUSINESS WIRE)--Q4 & YE 2021 Earnings notification |
Stevanato Group Appoints Riccardo Butta as President, AmericasPIOMBINO DESE, Italy, February 02, 2022--Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the appointment of Riccardo Butta to the role of President, Americas. |
First Bank & Trust Buys Daktronics Inc, Amgen Inc, Bristol-Myers Squibb Co, Sells Pfizer ...Investment company First Bank & Trust (Current Portfolio) buys Daktronics Inc, Amgen Inc, Bristol-Myers Squibb Co, Realty Income Corp, British American Tobacco PLC, sells Pfizer Inc, Canadian Imperial Bank of Commerce, Cisco Systems Inc, , Electronic Arts Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, First Bank & Trust. |
Stevanato Group Extends Pen Injector Technology Licensing Agreement With HaselmeierPIOMBINO DESE, Italy, January 26, 2022--Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an extension to its licensing agreement with Haselmeier, a company of the medmix group, for its Axis-D™ pen injector technology. |
Is Stevanato Group (STVN) A Smart Long-Term Buy?ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. During the third quarter, the ClearBridge SMID Cap Growth Strategy outperformed the benchmark Russell 2500 Growth Index. On an absolute basis, the Strategy had gains across five of the […] |
VIP Health Care Portfolio Buys Thermo Fisher Scientific Inc, Royalty Pharma PLC, Charles River ...Investment company VIP Health Care Portfolio (Current Portfolio) buys Thermo Fisher Scientific Inc, Royalty Pharma PLC, Charles River Laboratories International Inc, Alignment Healthcare Inc, Twist Bioscience Corp, sells Bristol-Myers Squibb Co, Regeneron Pharmaceuticals Inc, Novavax Inc, Anthem Inc, Turning Point Therapeutics Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, VIP Health Care Portfolio. |
Penn Series SMID Cap Growth Fund Buys Vail Resorts Inc, Workiva Inc, Core & Main Inc, Sells ...Investment company Penn Series SMID Cap Growth Fund (Current Portfolio) buys Vail Resorts Inc, Workiva Inc, Core & Main Inc, Axonics Inc, Ameresco Inc, sells Zendesk Inc, Bio-Techne Corp, 10x Genomics Inc, Molina Healthcare Inc, Azenta Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Penn Series SMID Cap Growth Fund. |
Neiman Funds Buys RBC Bearings Inc, Pool Corp, Coastal Financial Corp, Sells XPO Logistics Inc, ...Investment company Neiman Funds (Current Portfolio) buys RBC Bearings Inc, Pool Corp, Coastal Financial Corp, Catalent Inc, Avantor Inc, sells XPO Logistics Inc, Madison Square Garden Entertainment Corp, RedBall Acquisition Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Neiman Funds. |
Tekla World Healthcare Fund Buys Moderna Inc, Merck Inc, AstraZeneca PLC, Sells ResMed Inc, ...Investment company Tekla World Healthcare Fund (Current Portfolio) buys Moderna Inc, Merck Inc, AstraZeneca PLC, Guardant Health Inc, IDEXX Laboratories Inc, sells ResMed Inc, Anthem Inc, UnitedHealth Group Inc, AbbVie Inc, DexCom Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Tekla World Healthcare Fund. |
Stevanato Group Announces Expansion of Corporate HeadquartersPIOMBINO DESE (PD), Italy, November 17, 2021--Stevanato Group (NYSE: STVN) ("the Company"), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the expansion of its corporate headquarters with the construction of a new facility in Piombino Dese, Italy to advance operations and growth of the Company. |